Izotropic Provides Update on Annual General Meeting Materials and Voting Procedures
Izotropic (OTCQB: IZOZF), a medical device company developing the IzoView CT imaging system, has announced changes to its Annual General Meeting materials distribution due to a Canadian postal workers' strike. The company will not mail physical meeting materials but has made them available on SEDAR+ and the company website.
Shareholders can obtain voting control numbers by December 9, 2024, by contacting ir@izocorp.com and can vote online at vote.odysseytrust.com. Those who previously consented to electronic communications will receive materials and voting instructions via email from their respective holding organizations.
Izotropic (OTCQB: IZOZF), un'azienda di dispositivi medici che sta sviluppando il sistema di imaging CT IzoView, ha annunciato modifiche nella distribuzione dei materiali per l'Assemblea Generale Annuale a causa di uno sciopero dei lavoratori postali canadesi. L'azienda non invierà materiali fisici per la riunione, ma li ha resi disponibili su SEDAR+ e sul sito web dell'azienda.
Gli azionisti possono ottenere i numeri di controllo per il voto entro il 9 dicembre 2024, contattando ir@izocorp.com e possono votare online su vote.odysseytrust.com. Coloro che hanno precedentemente acconsentito a comunicazioni elettroniche riceveranno materiali e istruzioni per il voto tramite email dalle proprie organizzazioni di appartenenza.
Izotropic (OTCQB: IZOZF), una empresa de dispositivos médicos que está desarrollando el sistema de imagen CT IzoView, ha anunciado cambios en la distribución de sus materiales para la Junta General Anual debido a una huelga de los trabajadores postales canadienses. La empresa no enviará materiales físicos de la reunión, pero los ha puesto a disposición en SEDAR+ y en el sitio web de la empresa.
Los accionistas pueden obtener números de control de voto antes del 9 de diciembre de 2024, contactando ir@izocorp.com y pueden votar en línea en vote.odysseytrust.com. Aquellos que previamente consintieron a las comunicaciones electrónicas recibirán materiales e instrucciones para votar por correo electrónico a través de sus respectivas organizaciones de posesión.
Izotropic (OTCQB: IZOZF), IzoView CT 이미지 시스템을 개발 중인 의료 기기 회사가 캐나다 우체국 노동자 파업으로 인해 연례 총회 자료 배포 변경 사항을 발표했습니다. 회사는 물리적인 회의 자료를 우편으로 발송하지 않지만, SEDAR+와 회사 웹사이트에서 자료를 이용할 수 있도록 하였습니다.
주주들은 2024년 12월 9일까지 ir@izocorp.com에 연락하여 투표 제어 번호를 받을 수 있으며, vote.odysseytrust.com에서 온라인으로 투표할 수 있습니다. 이전에 전자 통신에 동의한 분들은 각각의 보유 조직으로부터 이메일을 통해 자료와 투표 지침을 받을 것입니다.
Izotropic (OTCQB: IZOZF), une entreprise de dispositifs médicaux développant le système d'imagerie CT IzoView, a annoncé des modifications concernant la distribution de ses matériaux pour l'Assemblée Générale Annuelle en raison d'une grève des travailleurs postaux canadiens. L'entreprise ne postalera pas de documents physiques pour la réunion, mais les a rendus disponibles sur SEDAR+ et sur le site web de l'entreprise.
Les actionnaires peuvent obtenir des numéros de contrôle de vote d'ici le 9 décembre 2024, en contactant ir@izocorp.com et peuvent voter en ligne sur vote.odysseytrust.com. Ceux qui ont précédemment donné leur consentement pour des communications électroniques recevront des documents et des instructions de vote par e-mail de leurs organisations de détention respectives.
Izotropic (OTCQB: IZOZF), ein Unternehmen für medizinische Geräte, das das IzoView CT-Bildgebungssystem entwickelt, hat Änderungen bei der Verteilung der Unterlagen zur ordentlichen Hauptversammlung bekannt gegeben, da es zu einem Streik der kanadischen Postangestellten kommt. Das Unternehmen wird keine physischen Versammlungsunterlagen per Post versenden, sondern diese auf SEDAR+ und der Unternehmenswebsite zur Verfügung stellen.
Aktionäre können bis zum 9. Dezember 2024 Abstimmungsnummern anfordern, indem sie ir@izocorp.com kontaktieren, und sie können online auf vote.odysseytrust.com abstimmen. Diejenigen, die zuvor in elektronische Kommunikation eingewilligt haben, erhalten die Materialien und Abstimmungshinweise per E-Mail von ihren jeweiligen Verwahrorganisationen.
- None.
- None.
Vancouver, British Columbia--(Newsfile Corp. - December 4, 2024) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing IzoView, a CT (computed tomography) imaging system, announces that due to the suspension of mail service in Canada due to the nationwide strike of the Canadian Union of Postal Workers, that the notice of meeting, information circular, requests for financial statements and proxy form (the "Meeting Materials") for the Company's upcoming Annual General Meeting will not be mailed and have been posted and are accessible on the Company's SEDAR+ profile and on the Company's website at https://izocorp.com/investors/agm/.
Shareholders may access the meeting materials at the aforementioned websites and can contact the Company at ir@izocorp.com to obtain their voting control numbers that will be available on or before December 9, 2024, to vote their shares online at https://vote.odysseytrust.com.
Registered and beneficial shareholders who have provided prior e-consent to either Izotropic's trust company, Odyssey Trust, or their brokerage house, depository company or other intermediary with which they hold their shares will receive their meeting materials, instructions on how to vote, and voting control number via email from the organization in which their shares are held to vote their shares online at https://vote.odysseytrust.com.
Copies of the Company's annual audited, and quarterly interim financial statements and management's discussion and analysis are accessible on the Company's Sedar+ profile and on the Company's website at https://izocorp.com/investors/financials/.
ON BEHALF OF THE BOARD
Mr. Robert Thast, CEO
Cell: 604-220-5031
Contact:
Email: info@izocorp.com
Toll Free: 1-833-IZOCORP ext.1
About Izotropic
More information about Izotropic Corporation can be found on its website at izocorp.com and by reviewing its profile on SEDAR at sedar.com.
Forward-Looking Statements
This document may contain statements that are "Forward-Looking Statements," which are based upon the current estimates, assumptions, projections, and expectations of the Company's management, business, and its knowledge of the relevant market and economic environment in which it operates. The Company has tried, where possible, to identify such information and statements by using words such as "anticipate," "believe," "envision," "estimate," "expect," "intend," "may," "plan," "predict," "project," "target," "potential," "will," "would," "could," "should," "continue," "contemplate" and other similar expressions and derivations thereof in connection with any discussion of future events, trends or prospects or future operating or financial performance, although not all forward-looking statements contain these identifying words.
These statements are not guarantees of performance and involve risks, including those related to capital requirements and uncertainties that are difficult to control or predict, and as such, they may cause future results of the Company's activity to differ significantly from the content and implications of such statements. Forward-Looking Statements are pertinent only as of the date on which they are made, and the Company undertakes no obligation to update or revise any Forward-Looking Statements to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law. Neither the Company nor its shareholders, officers, and consultants shall be liable for any action and the results of any action taken by any person based on the information contained herein, including, without limitation, the purchase or sale of Company securities. Nothing in this document should be deemed to be medical or other advice of any kind. All images are for illustrative purposes only. IzoView has not yet been approved or cleared for sale.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/232512
FAQ
How can shareholders access Izotropic's (IZOZF) 2024 AGM materials?
When will voting control numbers be available for Izotropic (IZOZF) shareholders?